Skip to main content
Clinical Trials/NCT03540641
NCT03540641CompletedNot Applicable

Effect of the Transcranial Magnetic Stimulation Applied on the Left Dorsolateral Prefrontal Cortex on the Clinical and Neuropsychological Variables in Subjects With Binge Eating Disorder

Universidad Autonoma de Queretaro2 sites in 1 country30 target enrollmentStarted: April 6, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
2
Primary Endpoint
Food Craving Inventory (FCI)

Study Overview

Brief Summary

This study evaluates de efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) applied on the left dorsolateral prefrontal cortex in patients with binge eating disorder.

Detailed Description

Binge Eating Disorder (BED) affects a significant percentage of de national population (1.4%) in a portio 2-1 in woman compared with men, the repetitive Transcranial Magnetic Stimulation (rTMS) is a neuromodulation technique, which allows us to induce brain electrical activity by plating magnetic fields and it has been proven that at 10Hz it has an effect of improvement in the craving of food.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subjects of both sexes.
  • Subjects from 18 to 45 years of age.
  • Subjects with diagnosis of binge eating disorder.
  • Subjects without changes in pharmacological treatment in the last 30 days.
  • Subjects who agree to sign the informed consent letter.

Exclusion Criteria

  • 1.Subjects with a history of traumatic brain injury with loss of consciousness. 2.Subjects with intracranial metallic objects or metal plates in the skull.
  • 3.Subjects who suffer chronic diseases not controlled at the time of entering the study (for example: hypertension, diabetes, rheumatic diseases).
  • 4.Patients with psychotic symptoms, bipolar affective disorders and substance dependence.
  • 5.Subjects with alterations in electroencephalogram (epileptiform activity). 6.Patients with any type of chronic or neurological medical disease not controlled.

Outcomes

Primary Outcomes

Food Craving Inventory (FCI)

Time Frame: 6 weeks

The FCI is a self-report inventory designed to measure the food craving, is made up of 37 elements and is a scale-likert instrument.

Secondary Outcomes

  • Barratt Impulsivity Scale (BIS-11)(6 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Julian Reyes López

professor

Universidad Autonoma de Queretaro

Study Sites (2)

Loading locations...

Similar Trials